Schedule 13G ownership disclosure

PYXIS ONCOLOGY INC

Common Stock, par value $0.001 per share · CUSIP: 747324101

Event date: 2024-12-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 3,133,292.00 · Class: 5.3%

  • Millennium Management LLC

    Shares: 3,160,139.00 · Class: 5.3%

  • Millennium Group Management LLC

    Shares: 3,160,139.00 · Class: 5.3%

  • Israel A. Englander

    Shares: 3,160,139.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-128889
Form type
SCHEDULE 13G
Filer
INTEGRATED CORE STRATEGIES (US) LLC
CIK
CIK 1319244
Filed
Dec 16, 2024
Reporting period
Dec 09, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub